Company Filing History:
1 out of 1,217 
1 out of 2,202 
Years Active: 1991-1992
Title: Hanah Margalit: Innovator in HIV Research
Introduction
Hanah Margalit is a prominent inventor based in Rockville, MD (US). She has made significant contributions to the field of HIV research, holding 2 patents that focus on innovative approaches to combat the AIDS virus. Her work has the potential to enhance immune responses against HIV, paving the way for future vaccine development.
Latest Patents
One of her latest patents is titled "Synthetic peptides sharing sequence homology with the HIV envelope." This invention relates to the identification of short peptide segments of AIDS virus proteins that elicit T cellular immunity. It also describes a method of inducing cellular immunity to native proteins of the AIDS virus by immunization with short synthetic peptides. Five potential peptides have been identified by searching for regions that can fold as a maximally amphipathic helix. These peptides may be useful in either a synthetic peptide- or recombinant fragment-based vaccine.
Another significant patent is "Synthetic vaccine against AIDS virus." This invention focuses on peptide antigens that stimulate helper T lymphocytes, which specifically recognize HIV envelope protein. This stimulation enhances antibody production and cytotoxic T cells to inhibit the expression of an infection caused by the HIV virus.
Career Highlights
Throughout her career, Hanah Margalit has worked with esteemed organizations, including the United States of America as represented by the Department of Health and the United States of America as represented by the Secretary of Health. Her innovative research has contributed to the understanding and potential treatment of HIV.
Collaborations
Hanah has collaborated with notable colleagues such as Jay A Berzofsky and James L Cornette. Their combined expertise has further advanced the research in the field of HIV and immunology.
Conclusion
Hanah Margalit is a trailblazer in HIV research, with her patents reflecting her commitment to developing effective solutions against the AIDS virus. Her work continues to inspire advancements in vaccine development and immunotherapy.